Diseases of the Nervous System, Phase III

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG).

Trial with
Janssen Research & Development, LLC
Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Richard Nowak

Richard.nowak@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Richard Nowak, MD, MS
Associate Professor of Neurology; Director, Program in Clinical & Translational Neuromuscular Research; Director, Yale Myasthenia Gravis Clinic

Sub-Investigator

Bhaskar Roy, MBBS, MHS

Last Updated
08/10/2023
Study HIC
#2000031341